ProfileGDS4718 / 211596_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 83% 74% 97% 82% 86% 82% 87% 81% 85% 87% 86% 79% 87% 90% 74% 90% 91% 90% 80% 76% 81% 85% 88% 88% 87% 91% 86% 88% 86% 88% 84% 87% 73% 80% 95% 93% 88% 83% 85% 98% 85% 86% 91% 83% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.230583
GSM549102patient 115, normal, homogenized [OPG study]7.2093174
GSM549104patient 119, normal, homogenized [OPG study]10.906297
GSM549108patient 138, normal, homogenized [OPG study]7.9293982
GSM549119patient 077, normal, homogenized [OPG study]8.583286
GSM549133patient 032, cancer, homogenized [OPG study]8.2055582
GSM549139patient 042, cancer, homogenized [OPG study]8.7280387
GSM549099patient 107, normal, homogenized [OPG study]7.9045281
GSM549109patient 139, normal, homogenized [OPG study]8.4185885
GSM549110patient 046, normal, homogenized [OPG study]8.6845587
GSM549114patient 063, normal, homogenized [OPG study]8.6780886
GSM549122patient 082, normal, homogenized [OPG study]7.6940779
GSM549134patient 033, cancer, homogenized [OPG study]8.7743887
GSM549136patient 036, cancer, homogenized [OPG study]9.2138490
GSM549140patient 044, cancer, homogenized [OPG study]7.3473374
GSM549111patient 047, normal, homogenized [OPG study]9.2809290
GSM549113patient 057, normal, homogenized [OPG study]9.4894191
GSM549132patient 031, cancer, homogenized [OPG study]9.220690
GSM549137patient 038, cancer, homogenized [OPG study]7.9276780
GSM549142patient 047, cancer, homogenized [OPG study]7.3236776
GSM549100patient 110, normal, homogenized [OPG study]7.9138381
GSM549107patient 135, normal, homogenized [OPG study]8.5327685
GSM549115patient 068, normal, homogenized [OPG study]9.0260288
GSM549116patient 072, normal, homogenized [OPG study]8.9257988
GSM549120patient 078, normal, homogenized [OPG study]8.7049887
GSM549131patient 030, cancer, homogenized [OPG study]9.346491
GSM549118patient 074, normal, homogenized [OPG study]8.6311486
GSM549129patient 027, cancer, homogenized [OPG study]8.852588
GSM549123patient 088, normal, homogenized [OPG study]8.5619386
GSM549124patient 006, cancer, homogenized [OPG study]8.7061388
GSM549126patient 015, cancer, homogenized [OPG study]8.2949784
GSM549128patient 025, cancer, homogenized [OPG study]8.7075887
GSM549103patient 117, normal, homogenized [OPG study]7.0131373
GSM549117patient 073, normal, homogenized [OPG study]7.9422680
GSM549138patient 041, cancer, homogenized [OPG study]10.277995
GSM549141patient 045, cancer, homogenized [OPG study]9.7968993
GSM549130patient 028, cancer, homogenized [OPG study]8.8024388
GSM549101patient 111, normal, homogenized [OPG study]8.1951383
GSM549105patient 128, normal, homogenized [OPG study]8.4374185
GSM549106patient 134, normal, homogenized [OPG study]11.685798
GSM549112patient 048, normal, homogenized [OPG study]8.4543685
GSM549125patient 011, cancer, homogenized [OPG study]8.5984486
GSM549127patient 024, cancer, homogenized [OPG study]9.265791
GSM549135patient 035, cancer, homogenized [OPG study]8.336883